Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3093

Actual shortage: 247 (8%)
Anticipated shortage: 14 (0%)
Avoided shortage: 9 (0%)
Resolved: 2823 (91%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

31 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-QUETIAPINE XR 50MG TABLET (EXTENDED-RELEASE) Resolved 2019-01-30 2020-11-03 74033
APO-DESVENLAFAXINE 50MG TABLET (EXTENDED-RELEASE) Resolved 2019-02-21 2019-04-05 76582
APO-METFORMIN ER 1000MG TABLET (EXTENDED-RELEASE) Resolved 2019-02-24 2019-04-15 76726
APO-QUETIAPINE XR 150MG TABLET (EXTENDED-RELEASE) Resolved 2019-02-24 2020-11-03 76735
APO-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Resolved 2019-02-24 2020-11-03 76740
APO-DESVENLAFAXINE 100MG TABLET (EXTENDED-RELEASE) Resolved 2019-04-10 2019-05-14 80926
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2019-04-24 2019-06-21 82337
APO-DESVENLAFAXINE 50MG TABLET (EXTENDED-RELEASE) Resolved 2019-04-30 2019-05-13 82837
APO-METFORMIN ER 1000MG TABLET (EXTENDED-RELEASE) Resolved 2019-05-08 2019-06-24 83504
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2019-05-15 2019-06-24 84159
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2019-06-05 2019-06-21 85619
APO-METFORMIN ER 1000MG TABLET (EXTENDED-RELEASE) Resolved 2019-07-03 2019-08-03 88336
APO-DESVENLAFAXINE 50MG TABLET (EXTENDED-RELEASE) Resolved 2019-08-21 2019-09-16 92019
APO-METFORMIN ER 1000MG TABLET (EXTENDED-RELEASE) Resolved 2019-08-21 2019-08-30 92026
APO-DESVENLAFAXINE 100MG TABLET (EXTENDED-RELEASE) Resolved 2019-09-25 2019-11-04 94734
APO-CLARITHROMYCIN XL 500MG TABLET (EXTENDED-RELEASE) Resolved 2019-10-02 2021-07-15 95266
APO-FELODIPINE 2.5MG TABLET (EXTENDED-RELEASE) Resolved 2019-10-16 2019-11-18 96647
APO-OXYCODONE CR 40MG TABLET (EXTENDED-RELEASE) Resolved 2019-11-27 2020-03-02 99792
APO-METFORMIN ER 1000MG TABLET (EXTENDED-RELEASE) Resolved 2019-12-05 2021-05-03 100281
APO-METFORMIN ER 500MG TABLET (EXTENDED-RELEASE) Resolved 2019-12-05 2023-07-04 100284

Showing 2881 to 2900 of 3093

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94446
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94449
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94452
APO-HYDROCHLOROTHIAZIDE Discontinued 2019-11-26 2019-11-26 99653
APO-IMIQUIMOD Discontinued 2019-11-26 2019-11-26 99672
APO-CARBAMAZEPINE Discontinued 2020-02-19 2020-02-19 106679
APO-NIZATIDINE 150MG CAPSULE Discontinued 2017-03-13 2017-03-13 1127
APO-NIZATIDINE 300MG CAPSULE Discontinued 2017-03-13 2017-03-13 1135
APO-NORTRIPTYLINE 10MG CAPSULE Discontinued 2017-03-13 2017-03-13 1145
APO-NORTRIPTYLINE 25MG CAPSULE Discontinued 2017-03-13 2017-03-13 1155
APO-GEMFIBROZIL CAP 300MG USP 300MG CAPSULE Discontinued 2017-03-31 2018-12-07 4920
APO-DOCUSATE SODIUM 100MG CAPSULE Discontinued 2018-02-23 2019-03-29 40733
DOCUSATE SODIUM CAPSULES 100MG CAPSULE Discontinued 2018-02-23 2018-09-15 40738
APO-AMOXI 250MG CAPSULE Discontinued 2018-09-07 2019-02-13 60171
APO-AMOXI 500MG CAPSULE Discontinued 2018-09-07 2018-11-09 60174
APO-ATOMOXETINE 60MG CAPSULE Discontinued 2018-09-07 2018-09-15 60273
APO-CELECOXIB 100MG CAPSULE To be discontinued 2018-09-07 2018-12-11 60363
APO-CELECOXIB 200MG CAPSULE Discontinued 2018-09-07 2021-01-21 60366
APO-CLINDAMYCIN 150MG CAPSULE To be discontinued 2018-09-07 2018-12-28 60396
APO-CLINDAMYCIN 300MG CAPSULE Discontinued 2018-09-07 2019-07-13 60399

Showing 41 to 60 of 356